ETH-50

N/A

Report date: 2026/05/12 09:09:49

Base Information

Drug NameETH-50
Drug Alias NameBetacoronavirus vaccine (DIOSynVax/CEPI)Betacoronavirus vaccine (DIOSynVax/CEPI/Ethris)SARS-CoV-2 vaccine (DIOSynVax/CEPI)ETH-50
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiosynvax Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDiosynvax LtdEthris GmbH
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A